1	Mitsui	_	NNP	_	_	4	SBJ	_	_
2	&	_	CC	_	_	1	COORD	_	_
3	Co.	_	NNP	_	_	2	CONJ	_	_
4	said	_	VBD	_	_	0	ROOT	_	_
5	it	_	PRP	_	_	6	SBJ	_	_
6	started	_	VBD	_	_	4	OBJ	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	joint	_	JJ	_	_	9	NMOD	_	_
9	venture	_	NN	_	_	6	OBJ	_	_
10	with	_	IN	_	_	9	NMOD	_	_
11	Dae	_	NNP	_	_	13	NAME	_	_
12	Woong	_	NNP	_	_	13	NAME	_	_
13	Chemical	_	NNP	_	_	10	PMOD	_	_
14	Co.	_	NNP	_	_	13	POSTHON	_	_
15	,	_	,	_	_	13	P	_	_
16	a	_	DT	_	_	19	NMOD	_	_
17	major	_	JJ	_	_	19	NMOD	_	_
18	pharmaceutical	_	JJ	_	_	19	NMOD	_	_
19	manufacturer	_	NN	_	_	13	APPO	_	_
20	in	_	IN	_	_	19	LOC	_	_
21	South	_	NNP	_	_	22	NAME	_	_
22	Korea	_	NNP	_	_	20	PMOD	_	_
23	,	_	,	_	_	13	P	_	_
24	to	_	TO	_	_	9	NMOD	_	_
25	manufacture	_	VB	_	_	24	IM	_	_
26	antibiotic	_	JJ	_	_	27	NMOD	_	_
27	medicines	_	NNS	_	_	25	OBJ	_	_
28	.	_	.	_	_	4	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	new	_	JJ	_	_	3	NMOD	_	_
3	company	_	NN	_	_	4	SBJ	_	_
4	is	_	VBZ	_	_	0	ROOT	_	_
5	capitalized	_	VBN	_	_	4	VC	_	_
6	at	_	IN	_	_	5	ADV	_	_
7	about	_	RB	_	_	8	DEP	_	_
8	$	_	$	_	_	6	PMOD	_	_
9	3.5	_	CD	_	_	8	DEP	_	_
10	million	_	CD	_	_	8	DEP	_	_
11	.	_	.	_	_	4	P	_	_

1	Mitsui	_	NNS	_	_	2	SBJ	_	_
2	expects	_	VBZ	_	_	0	ROOT	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	antibiotic	_	JJ	_	_	5	NMOD	_	_
5	products	_	NNS	_	_	2	OBJ	_	_
6	to	_	TO	_	_	2	OPRD	_	_
7	be	_	VB	_	_	6	IM	_	_
8	exported	_	VBN	_	_	7	VC	_	_
9	to	_	TO	_	_	8	DIR	_	_
10	Southeast	_	NNP	_	_	11	NAME	_	_
11	Asia	_	NNP	_	_	9	PMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	Africa	_	NNP	_	_	12	CONJ	_	_
14	.	_	.	_	_	2	P	_	_

1	It	_	PRP	_	_	3	SBJ	_	_
2	also	_	RB	_	_	3	ADV	_	_
3	hopes	_	VBZ	_	_	0	ROOT	_	_
4	to	_	TO	_	_	3	OPRD	_	_
5	enter	_	VB	_	_	4	IM	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	U.S.	_	NNP	_	_	8	NMOD	_	_
8	market	_	NN	_	_	5	OBJ	_	_
9	.	_	.	_	_	3	P	_	_

